VERVE THERAPEUTICS INC's ticker is VERV and the CUSIP is 92539P101. A total of 96 filers reported holding VERVE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 2.38 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $64,085,157 | -16.5% | 4,832,968 | +18.1% | 0.00% | 0.0% |
| Q2 2023 | $76,710,282 | +37.1% | 4,091,215 | +5.5% | 0.00% | +100.0% |
| Q1 2023 | $55,933,017 | -24.2% | 3,878,850 | +1.8% | 0.00% | -50.0% |
| Q4 2022 | $73,762,664 | -41.3% | 3,812,024 | +4.2% | 0.00% | -50.0% |
| Q3 2022 | $125,680,000 | +251.2% | 3,658,812 | +56.2% | 0.00% | +300.0% |
| Q2 2022 | $35,789,000 | -32.4% | 2,342,193 | +1.0% | 0.00% | 0.0% |
| Q1 2022 | $52,915,000 | +5.2% | 2,318,775 | +70.0% | 0.00% | 0.0% |
| Q4 2021 | $50,300,000 | -16.6% | 1,364,221 | +6.4% | 0.00% | 0.0% |
| Q3 2021 | $60,279,000 | +1438.9% | 1,282,542 | +1873.1% | 0.00% | – |
| Q2 2021 | $3,917,000 | – | 65,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alphabet Inc. | 10,974,011 | $661,184,000 | 13.47% |
| Casdin Capital, LLC | 3,038,167 | $183,050,000 | 4.65% |
| Logos Global Management LP | 758,265 | $45,685,000 | 3.84% |
| Novo Holdings A/S | 793,265 | $47,794,000 | 2.12% |
| Redmile Group, LLC | 1,936,530 | $116,676,000 | 1.73% |
| Cormorant Asset Management, LP | 709,224 | $40,594,000 | 1.38% |
| Rock Springs Capital Management LP | 962,826 | $58,011,000 | 1.15% |
| Asymmetry Capital Management, L.P. | 24,790 | $1,494,000 | 1.03% |
| Darwin Global Management, Ltd. | 103,013 | $6,207,000 | 1.00% |
| RA Capital Management | 880,284 | $53,037,000 | 0.85% |